CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases of $8.96 million for the 9-month period ending 2013-09-28, per its 10-Q filed 2013-10-30.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases · last filed 2014-04-30
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for the quarter ending 2013-09-28 was $0.00.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for the quarter ending 2013-06-29 was $0.00.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for the quarter ending 2013-03-30 was $8.96M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for the quarter ending 2012-09-29 was $0.00.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases 9 month |
|---|---|---|---|
| 2013-09-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | $0.00 derived: sum of 2 quarters · filed 2013-10-30 | $8.96M 10-Q · filed 2013-10-30 |
| 2013-06-29 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-31 | $8.96M 10-Q · filed 2013-07-31 | |
| 2013-03-30 | $8.96M 10-Q · filed 2014-04-30 | ||
| 2012-09-29 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | $0.00 derived: sum of 2 quarters · filed 2013-10-30 | $0.00 10-Q · filed 2013-10-30 |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-31 | $0.00 10-Q · filed 2013-07-31 | |
| 2012-03-31 | $0.00 10-Q · filed 2013-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |